TearScience develops, manufactures and markets ophthalmic medical devices aiding in the identification and treatment of Meibomian gland Dysfunction, also known as Dry eye disease. LipiView Ocular Surface uses Interferometry to measure the thickness of the tear film oily lipid layer and LipiFlow Thermal Pulsation System uses heat and pressure to unblock obstructed Meibomian glands to reduce dry eye symptoms.

Company Growth (employees)
Morrisville, US
Size (employees)
65 (est)-2%
TearScience was founded in 2005 and is headquartered in Morrisville, US

Key People/Management at TearScience

Steve Grenon

Steve Grenon

VP, Research & Development
Diethart Reichardt

Diethart Reichardt

SVP - European Region
Doug Pinotti

Doug Pinotti

GM, Asia Pacific & Latin America
Donald Korb

Donald Korb

CTO & Co - Founder
Wade Hampton

Wade Hampton

Chief Commercial Officer

TearScience Office Locations

TearScience has an office in Morrisville
Morrisville, US (HQ)
250 5151 McCrimmon Pkwy
Show all (1)

TearScience Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$148.9 m

Latest funding size

$19.2 m

Time since last funding

almost 2 years


TearScience's latest funding round in April 2016 was reported to be $19.2 m. In total, TearScience has raised $148.9 m

TearScience's Web-traffic and Trends

TearScience Online and Social Media Presence

TearScience Company Life and Culture

You may also be interested in